Myxobacteria: Chemical Diversity and Screening Strategies

Natural Products: Discourse, Diversity, and Design

Volumn , Issue , 2014, Pages 103-124

  Plaza, Alberto ^a,b   Müller, Rolf ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Antimicrobial discovery; Biodiversity guided isolation; LC ESIMS; Myxobacteria; Myxobacterial natural products; NMR

Indexed keywords

EID: 84906244413     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118794623.ch6     Document Type: Chapter

References (78)

1. Reichenbach, H.; Gerth, K.; Irschik, H.; Kunze, B. Myxobacteria: a source of new antibiotics. Trends Biotechnol. 1988, 6, 115-121.
2. Reichenbach, H. Myxobacteria, producers of novel bioactive substances. J. Ind. Microbiol. Biot. 2001, 27, 149-156.
3. Reichenbach, H.; Höfle, G. Myxobacteria as producers of secondary metabolites. In Drug Discovery from Nature; Grabley, S., Thiericke, R., Eds.; Springer: Berlin, 1999; pp 149-179.
4. Nan, B.; Zusman, D. R. Uncovering the mystery of gliding motility in the myxobacteria. Annu. Rev. Genet. 2011, 45, 21-39.
5. Dawid, W. Biology and global distribution of myxobacteria in soils. FEMS Microbiol. Rev. 2000, 24, 403-427.
6. Berleman, J. E.; Kirby, J. R. Deciphering the hunting strategy of a bacterial wolfpack. FEMS Microbiol. Rev. 2009, 33, 942-957.
7. Weissman, K. J.;Müller, R. A brief tour of myxobacterial secondary metabolism. Bioorgan. Med. Chem. 2009, 17, 2121-2136.
8. Wenzel, S. C.; Müller, R. The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat. Prod. Rep. 2009, 26, 1385-1407.
9. Xiao, Y.; Wei, X. M.; Ebright, R.; Wall, D. Antibiotic production by myxobacteria plays a role in predation. J. Bacteriol. 2011, 193, 4626-4633.
10. Wenzel, S. C.; Müller, R. The biosynthetic potential of myxobacteria and their impact on drug discovery. Curr. Opin. Drug. Discov. Devel. 2009, 12, 220-230.
11. Bode, H. B.;Müller, R. Secondary metabolism in myxobacteria. In Myxobacteria: Multicellularity and Differentiation; Whitworth, D., Ed.; ASM Press: Chicago, 2007; pp 259-282.
12. Johnson, T. A.; Sohn, J.; Vaske, Y. M.; White, K. N.; Cohen, T. L.; Vervoort, H. C.; Tenney, K.; Valeriote, F. A.; Bjeldanes, L. F.; Crews, P. Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC-MS/ELSD libraries. Bioorgan. Med. Chem. 2012, 20, 4348-4355.
13. Weissman, K. J.; Müller, R. Myxobacterial secondary metabolites: bioactivities and modes-ofaction. Nat. Prod. Rep. 2010, 27, 1276-1295.
14. Conlin, A.; Fornier, M.; Hudis, C.; Kar, S.; Kirkpatrick, P. Ixabepilone. Nat. Rev. Drug Discov. 2007, 6, 953-954.
15. Cortina, N. S.; Krug, D.; Plaza, A.; Revermann, O.;Müller, R. Myxoprincomide: a natural product from Myxococcus xanthus discovered by comprehensive analysis of the secondary metabolome. Angew. Chem. Int. Edit. 2012, 51, 811-816.
16. Plaza, A.; Garcia, R.; Bifulco, G.; Martinez, J. P.; Huttel, S.; Sasse, F.;Meyerhans, A.; Stadler, M.; Muller, R. Aetheramides A and B, potent HIV-inhibitory depsipeptides from a myxobacterium of the new genus "Aetherobacter". Org. Lett. 2012, 14, 2854-2857.
17. Sasse, F.; Steinmetz, H.; Heil, J.; Höfle, G.; Reichenbach, H. Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli: production, isolation, physico-chemical and biological properties. J. Antibiot. 2000, 53, 879-885.
18. Steinmetz, H.; Glaser, N.; Herdtweck, E.; Sasse, F.; Reichenbach, H.; Höfle, G. Isolation, crystal and solution structure determination, and biosynthesis of tubulysins-powerful inhibitors of tubulin polymerization from myxobacteria. Angew. Chem. Int. Edit. 2004, 43, 4888-4892.
19. Patterson, A.W.; Peltier, H. M.; Sasse, F.; Ellman, J. A. Design, synthesis, and biological properties of highly potent tubulysin D analogues. Chem. Eur. J. 2007, 13, 9534-9541.
20. Sandmann, A.; Sasse, F.;Müller, R. Identification and analysis of the core biosynthetic machinery of tubulysin, a potent cytotoxin with potential anticancer activity. Chem. Biol. 2004, 11, 1071-1079.
21. Ullrich, A.; Chai, Y.; Pistorius, D.; Elnakady, Y. A.; Herrmann, J.;Weissman, K. J.; Kazmaier, U.; Müller, R. Pretubulysin, a potent and chemically-accessible tubulysin precursor from Angiococcus disciformis. Angew. Chem. Int. Edit. 2009, 48, 4422-4425.
22. Chai, Y.; Pistorius, D.; Ullrich, A.; Weissman, K. J.; Kazmaier, U.; Müller, R. Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004. Chem. Biol. 2010, 17, 296-309.
23. Herrmann, J.; Elnakady, Y. A.;Wiedmann, R. M.; Ullrich, A.; Rohde, M.; Kazmaier, U.; Vollmar, A. M.; Muller, R. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy. PLOS ONE. 2012, 7, e37416.
24. Eirich, J.; Burkhart, J. L.; Ullrich, A.; Rudolf, G. C.; Vollmar, A.; Zahler, S.; Kazmaier, U.; Sieber, S. A. Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopy. Mol. Biosyst. 2012, 8, 2067-2075.
25. Zander, W.; Irschik, H.; Augustiniak, H.; Herrmann, M.; Jansen, R.; Steinmetz, H.; Gerth, K.; Kessler, W.; Kalesse, M.; Höfle, G.; Müller, R. Sulfangolids, macrolide sulfate esters from Sorangium cellulosum. Chem. Eur. J. 2012, 18, 6264-6271.
26. Jansen, R.; Irschik, H.; Huch,V.; Schummer, D.; Steinmetz, H.; Bock, M.; Schmidt, T.; Kirschning, A.; Müller, R. Carolacton-a macrolide ketocarbonic acid reducing biofilm formation by the caries- and endocarditis-associated bacterium Streptococcus mutans. Eur. J. Org. Chem. 2010, 1284-1289.
27. Schmidt, T.; Kirschning, A. Total synthesis of carolacton, a highly potent biofilm inhibitor. Angew. Chem. Int. Edit. 2012, 51, 1063-1066.
28. Kunze, B.; Reck, M.; Dotsch, A.; Lemme, A.; Schummer, D.; Irschik, H.; Steinmetz, H.;Wagner-Dobler, I. Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum. BMC Microbiol. 2010, 10, 199.
29. Reck, M.; Rutz, K.; Kunze, B.; Tomasch, J.; Surapaneni, S. K.; Schulz, S.; Wagner-Döbler, I. The biofilm inhibitor carolacton disturbs membrane integrity and cell division of Streptococcus mutans through the serine/threonine protein kinase PknB. J. Bacteriol. 2011, 193, 5692-5706.
30. Horstmann, N.; Essig, S.; Bockelmann, S.;Wieczorek, H.; Huss, M.; Sasse, F.; Menche, D. Archazolid A-15-O-β-D-glucopyranoside and iso-archazolid B: potent V-ATPase inhibitory polyketides from the myxobacteria cystobacter violaceus and archangium gephyra. J. Nat. Prod. 2011, 74, 1100-1105.
31. Bockelmann, S.; Menche, D.; Rudolph, S.; Bender, T.; Grond, S.; von Zezschwitz, P.; Muench, S. P.; Wieczorek, H.; Huss, M. Archazolid A binds to the equatorial region of the c-ring of the vacuolar H+-ATPase. J. Biol. Chem. 2010, 285, 38304-38314.
32. Dreisigacker, S.; Latek, D.; Bockelmann, S.; Huss, M.; Wieczorek, H.; Filipek, S.; Gohlke, H.; Menche, D.; Carlomagno, T. Understanding the inhibitory effect of highly potent and selective archazolides binding to the vacuolar ATPase. J. Chem. Inf. Model. 2012, 52, 2265-2272.
33. Wiedmann, R. M.; von Schwarzenberg, K.; Palamidessi, A.; Schreiner, L.; Kubisch, R.; Liebi, J.; Schempp, C.; Trauner, D.; Zahler, S.; Wagner, E.; Müller, R.; Scita, G.; Vollmar, A. M. The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1. Cancer Res. 2012, 72, 5976-5987.
34. Wang, J.; Zhang, H.;Ying, L.;Wang, C.; Jiang, N.; Zhou,Y.;Wang, H.; Bai, H. Five newepothilone metabolites from Sorangium cellulosum strain So0157-2. J. Antibiot. 2009, 62, 483-487.
35. Wang, J.; Jiang, N.; Zhang, H.; Ying, L.; Wang, C.; Xiang, W.; Wu, B.; Wang, H.; Bai, H. New epothilone congeners from Sorangium cellulosum strain So0157-2. Nat. Prod. Res. 2011, 25, 1707-1712.
36. Zander,W.; Gerth, K.; Mohr, K. L.; Kessler,W.; Jansen, R.;Müller, R. Roimatacene: an antibiotic against gram-negative bacteria isolated from Cystobacter ferrugineus Cb G35 (myxobacteria). Chem. Eur. J. 2011, 17, 7875-7881.
37. Reichenbach, H.; Höfle, G.; Böhlendorf, B.; Irschik, H. Icumazoles and preparation processes. 1994.
38. Barbier, J.; Jansen, R.; Irschik, H.; Benson, S.; Gerth, K.; Böhlensorf, B.; Höfle, G.; Reichenbach, H.; Wegner, J.; Zeilinger, C.; Kirschning, A.; Müller, R. Isolation and total synthesis of icumazoles and noricumazoles - antifungal antibiotics and cation-channel blockers from Sorangium cellulosum. Angew. Chem. Int. Edit. 2012, 51, 1256-1260.
39. Kwak, J.; Ahn, J.W. A new cytotoxic spiroketal from the myxobacterium Sorangium cellulosum. Arch. Pharm. Res. 2009, 32, 841-844.
40. Niggemann, J.; Bedorf, N.; Flörke, U.; Steinmetz, H.; Gerth, K.; Reichenbach, H.; Höfle, G. Spirangien A and B, highly cytotoxic and antifungal spiroketals from the myxobacterium Sorangium cellulosum: isolation, structure elucidation and chemical modifications. Eur. J. Org. Chem. 2005, 2005, 5013-5018.
41. Ahn, J. W. Spirodienal C, a new spiroketal produced by Sorangium cellulosum (Myxobacteria). Arch. Pharm. Res. 2009, 32, 841-844.
42. Ohlendorf, B.; Lorenzen, W.; Kehraus, S.; Krick, A.; Bode, H. B.; König, G. Myxotyrosides A and B, unusual rhamnosides from Myxococcus sp. J. Nat. Prod. 2009, 72, 82-86.
43. Okanya, P.W.; Mohr, K. I.; Gerth, K.; Steinmetz, H.; Huch, V.; Jansen, R.;Müller, R. Hyaladione, an S-methyl cyclohexadiene-dione from Hyalangium minutum. J. Nat. Prod. 2012, 75, 768-770.
44. Bode, H. B.; Zeggel, B.; Silakowski, B.; Wenzel, S. C.; Reichenbach, H.; Müller, R. Steroid biosynthesis in prokaryotes: identification of myxobacterial steroids and cloning of the first bacterial 2,3(S)-oxidosqualene cyclase from the myxobacterium Stigmatella aurantiaca. Mol. Microbiol. 2003 47, 471-481.
45. Gawas, D.; Garcia, R.; Huch, V.; Müller, R. A highly conjugated dihydroxylated C-28 steroid from a myxobacterium. J. Nat. Prod. 2011, 74, 1281-1283.
46. Zander, W.; Mohr, K.; Gerth, K.; Jansen, R.; Müller, R. p-Hydroxyacetophenone amides from Cystobacter ferrugineus, strain Cb G35. J. Nat. Prod. 2011, 74, 1358-1363.
47. Maskey, R. P.; Asolkar, R. N.; Kapaun, E.; Wagner-Döbler, I.; Laatsch, H. Phytotoxic arylethylamides from limnic bacteria using a screening with microalgae. J. Antibiot. 2002, 55, 643-649.
48. Böröczky, K.; Laatsch, H.;Wagner-Döbler, I.; Stritzke, K.; Schulz, S. Cluster analysis as selection and dereplication tool for the identification of new natural compounds from large sample sets. Chem. Biodiver. 2006, 3, 622-634.
49. Garcia, R. O.; Krug, D.;Müller, R. Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods. Methods Enzymol. 2009, 458, 59-91.
50. Garcia, R. O.; Reichenbach, H.; Ring, M.W.;Müller, R. Phaselicystis flava gen. nov., sp. nov., an arachidonic acid-containing soil myxobacterium, and the description of Phaselicystidaceae fam. nov. Int. J. Syst. Evol. Micr. 2009, 59, 1524-1530.
51. Garcia, R.; Gerth, K.; Stadler, M.; Dogma, I. J., Jr.;Müller, R. Expanded phylogeny of myxobacteria and evidence for cultivation of the 'unculturables'. Mol. Phylogenet. Evol. 2010, 57, 878-887.
52. Gerth, K.; Steinmetz, H.; Hofle, G.; Jansen, R. Chlorotonil A, a macrolide with a unique gemdichloro-1,3-dione functionality from Sorangium cellulosum, So ce1525. Angew. Chem. Int. Edit. 2008, 47, 600-602.
53. Bifulco, G.; Dambruoso, P.; Gomez-Paloma, L.; Riccio, R. Determination of relative configuration in organic compounds by NMR spectroscopy and computational methods. Chem. Rev. 2007, 107, 3744-3779.
54. Bifulco, G.; Bassarello, C.; Riccio, R.; Gomez-Paloma, L. Quantum mechanical calculations of NMR J coupling values in the determination of relative configuration in organic compounds. Org. Lett. 2004, 6, 1025-1028.
55. Fischbach, M. A.; Walsh, C. T. Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem. Rev. 2006, 106, 3468-3496.
56. Bode, H. B.; Müller, R. The impact of bacterial genomics on natural product research. Angew. Chem. Int. Edit. 2005, 44, 6828-6846.
57. Walsh, C. T.; Fischbach, M. A. Natural products version 2.0: connecting genes to molecules. J. Am. Chem. Soc. 2010, 132, 2469-2493.
58. Schneiker, S.; Perlova, O.; Kaiser, O.; Gerth, K.; Alici, A.; Altmeyer, M. O.; Bartels, D.; Bekel, T.; Beyer, S.; Bode, E.; Bode, H. B.; Bolten, C. J.; Choudhuri, J. V.; Doss, S.; Elnakady, Y. A.; Frank, B.; Gaigalat, L.; Goesmann, A.; Groeger, C.; Gross, F.; Jelsbak, L.; Jelsbak, L.; Kalinowski, J.; Kegler, C.; Knauber, T. Konietzny, S.; Kopp, M.; Krause, L.; Krug, D.; Linke, B.; Mahmud, T.; Martinez-Arias, R.; McHardy, A. C.; Merai, M.; Meyer, F.; Mormann, S.; Munoz-Dorado, J.; Perez, J.; Pradella, S.; Rachid, S.; Raddatz, G.; Rosenau, F.; Rückert, C.; Sasse, F.; Scharfe, M.; Schuster, S. C.; Suen, G.; Treuner-Lange, A.; Velicer, G. J.; Vorhölter, F. J.; Weissman, K. J.; Welch, R. D.; Wenzel, S. C.; Whitworth, D. E.; Wilhelm, S.; Wittmann, C.; Blöcker, H.; Pühler, A.; Müller, R. Complete genome sequence of the myxobacterium Sorangium cellulosum. Nat. Biotechnol. 2007, 25, 1281-1289.
59. Ivanova, N.; Daum, C.; Lang, E.; Abt, B.; Kopitz, M.; Saunders, E.; Lapidus, A.; Lucas, S.; Del Rio, T. G.; Nolan, M.; Tice, H.; Copeland, A.; Cheng, J. F.; Chen, F.; Bruce, D.; Goodwin, L.; Pitluck, S.; Mavromatis, K.; Pati, A.; Mikhailova, N.; Chen, A.; Palaniappan, K.; Land, M.; Hauser, L.; Chang, Y. J.; Jeffries, C. D.; Detter, J. C.; Brettin, T.; Rohde, M.; Goker, M.; Bristow, J.; Markowitz, V.; Eisen, J. A.; Hugenholtz, P.; Kyrpides, N. C.; Klenk, H. P. Complete genome sequence of Haliangium ochraceum type strain (SMP-2(T)). Stand Genomic Sci. 2010, 2, 96-106.
60. Goldman, B. S.; Nierman, W. C.; Kaiser, D.; Slater, S. C.; Durkin, A. S.; Eisen, J.; Ronning, C. M.; Barbazuk, W. B.; Blanchard, M.; Field, C.; Halling, C.; Hinkle, G.; Iartchuk, O.; Kim, H. S.; Mackenzie, C.; Madupu, R.; Miller, N.; Shvartsbeyn, A.; Sullivan, S. A.; Vaudin, M.; Wiegand, R.; Kaplan, H. B. Evolution of sensory complexity recorded in a myxobacterial genome. Proc. Natl. Acad. Sci. 2006, 103, 15200-15205.
61. Li, Z. F.; Li, X.; Liu, H. Liu, X.; Han, K.;Wu, Z. H.; Hu,W.; Li, F. F.; Li, Y. Z. Genome sequence of the halotolerant marine bacterium Myxococcus fulvus HW-1. J. Bacteriol. 2011, 193, 5015-5016.
62. Ronning, C. M.; Nierman,W. C. The genomes of Myxococcus xanthus and Stigmatella aurantiaca. In Myxobacteria: Multicellularity and Differentiation; Whitworth, D., Ed.; ASM Press: Chicago, 2007; pp 285-298.
63. Huntley, S.; Zhang, Y.; Treuner-Lange, A.; Kneip, S.; Sensen, C. W.; Søgaard-Andersen, L. Complete genome sequence of the fruiting myxobacterium Corallococcus coralloides DSM 2259. J. Bacteriol. 2012, 194, 3012-3013.
64. Schley, C.; Altmeyer, M. O.; Swart, R.;Müller, R.; Huber, C. G. Proteome analysis of Myxococcus xanthus by off-line two-dimensional chromatographic separation using monolithic poly-(styrenedivinylbenzene) columns combined with ion-trap tandem mass spectrometry. J. Proteome Res. 2006, 5, 2760-2768.
65. Bode, H. B.; Ring, M.W.; Schwär, G.; Altmeyer, M. O.; Kegler, C.; Jose, I. R.; Singer, M.;Müller, R. Identification of additional players in the alternative biosynthesis pathway to isovaleryl-CoA in the myxobacterium Myxococcus xanthus. ChemBioChem 2009, 10, 128-140.
66. Aberg, K. M.; Torgrip, R. J. O.; Kolmert, J.; Schuppe-Koistinen, I.; Lindberg, J. Feature detection and alignment of hyphenated chromatographic-mass spectrometric data - Extraction of pure ion chromatograms using Kalman tracking. J. Chromatogr. A. 2008, 1192, 139-146.
67. Krug, D.; Zurek, G.; Schneider, B.; Garcia, R.; Müller, R. Efficient mining of myxobacterial metabolite profiles enabled by liquid chromatography-electrospray ionization-time-of-flight mass spectrometry and compound-based principal component analysis. Anal. Chim. Acta 2008, 624, 97-106.
68. Krug, D.; Zurek, G.; Revermann, O.; Vos, M.; Velicer, G. J.; Müller, R. Discovering the hidden secondary metabolome of Myxococcus xanthus: a study of intraspecific diversity. Appl. Environ. Microb. 2008, 74, 3058-3068.
69. Pistorius, D.; Müller, R. Discovery of the rhizopodin biosynthetic gene cluster in Stigmatella aurantiaca Sg a15 by genome mining. ChemBioChem 2012, 13, 416-426.
70. Wenzel, S. C.; Müller, R. Recent developments towards the heterologous expression of complex bacterial natural product biosynthetic pathways. Curr. Opin. Biotechnol. 2005, 16, 594-606.
71. Fu, J.; Wenzel, S. C.; Perlova, O.; Wang, J.; Gross, F.; Tang, Z.; Yin, Y.; Stewart, A. F.; Müller, R.; Zhang, Y. Efficient transfer of two large secondary metabolite pathway gene clusters into heterologous hosts by transposition. Nucleic Acids Res. 2008, 36, e113.
72. Buntin, K.; Irschik, H.; Weissman, K. J.; Luxenburger, E.; Blöcker, H.; Müller, R. Biosynthesis of thuggacins in myxobacteria: comparative cluster analysis reveals basis for natural product structural diversity. Chem. Biol. 2010, 17, 342-356.
73. Chai, Y.; Shan, S.; Weissman, K. J.; Hu, S.; Zhang, Y.; Müller, R. Heterologous expression and genetic engineering of the tubulysin biosynthetic gene cluster using Red/ET recombineering and inactivation mutagenesis. Chem. Biol. 2012, 19, 361-371.
74. Rachid, S.; Sasse, F.; Beyer, S.; Müller, R. Identification of StiR, the first regulator of secondary metabolite formation in the myxobacterium Cystobacter fuscus Cb f17.1. J. Biotechnol. 2006, 121, 429-441.
75. Rachid, S.; Gerth, K.; Kochems, I.; Müller, R. Deciphering regulatory mechanisms for secondary metabolite production in the myxobacterium Sorangium cellulosum So ce56. Mol. Microbiol. 2007, 63, 1783-1796.
76. Rachid, S.; Gerth, K.;Müller, R. NtcA-A negative regulator of secondary metabolite biosynthesis in Sorangium cellulosum. J. Biotechnol. 2008, 140, 135-142.
77. Volz, C.; Kegler, C.; Müller, R. Enhancer binding proteins act as hetero-oligomers and link secondary metabolite production to myxococcal development, motility, and predation. Chem. Biol. 2012, 19, 1447-1459.
78. Hüttel, S.; Müller, R. Methods to optimize myxobacterial fermentations using off-gas analysis. Microb. Cell Fact. 2012, 11, 59.